Table 1 Demographics of patients with schizophrenia and healthy controls.

From: The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation

Characteristics categories

SCZ (n = 204)

HC (n = 216)

t/χ2

P

Age (years) (mean ± SD)

44.37 ± 6.83

43.78 ± 7.17

0.86

0.389a

BMI (kg/m2) (mean ± SD)

24.40 ± 3.48

23.95 ± 3.36

1.33

0.184a

Gender, n (%)

ā€ƒMale

132 (64.7%)

135 (62.5%)

Ā Ā 

ā€ƒFemale

72 (35.3%)

81 (37.5%)

0.22

0.639b

Ethnic, n (%)

ā€ƒHans

86 (42.2%)

76 (35.2%)

Ā Ā 

ā€ƒUyghurs

118 (57.8%)

140 (64.8%)

2.15

0.142b

Family location, n (%)

ā€ƒUrban

95 (46.6%)

101 (46.8%)

Ā Ā 

ā€ƒRural

109 (53.4%)

115 (53.2%)

0.00

0.969b

Education level, n (%)

ā€ƒElementary school

28 (13.7%)

32 (14.8%)

Ā Ā 

ā€ƒMiddle school

89 (43.6%)

86 (39.8%)

Ā Ā 

ā€ƒHigh school

75 (36.8%)

81 (37.5%)

Ā Ā 

ā€ƒUniversity and above

12 (5.9%)

17 (7.9%)

1.07

0.785b

Marital status, n (%)

ā€ƒUnmarried

71 (34.8%)

70 (32.4%)

Ā Ā 

ā€ƒMarried

78 (38.2%)

85 (39.3%)

Ā Ā 

ā€ƒDivorced

53 (26.0%)

58 (26.9%)

Ā Ā 

ā€ƒWidowed

2 (1.0%)

3 (1.4%)

0.47

0.946c

Smoking, n (%)

ā€ƒYes

59 (28.9%)

64 (29.6%)

Ā Ā 

ā€ƒNo

145 (71.1%)

152 (70.4%)

0.03

0.873b

Age of onset (years) (mean ± SD)

22.43 ± 3.20

Ā Ā Ā 

Duration of illness (years) (mean ± SD)

21.94 ± 7.13

Ā Ā Ā 

Equivalent dose of chlorpromazine (mg/day) (mean ± SD)

592.84 ± 164.90

Ā Ā Ā 

Equivalent dose of lorazepam (mg/day) (mean ± SD)

1.58 ± 0.70

Ā Ā Ā 
  1. SCZ Schizophrenia, HC healthy controls, BMI body mass index.
  2. aMeans Independent samples t-test.
  3. bMeans χ2 test.
  4. cFisher’s exact test.